Expert consensus of management of adverse drug reactions with anaplastic lymphoma kinase tyrosine kinase inhibitors
间变性淋巴瘤激酶酪氨酸激酶抑制剂不良药物反应管理的专家共识
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2023.101560
Zhou, F; Yang, Y; Zhang, L; Cheng, Y; Han, B; Lu, Y; Wang, C; Wang, Z; Yang, N; Fan, Y; Wang, L; Ma, Z; Zhang, L; Yao, Y; Zhao, J; Dong, X; Zhu, B; Zhou, C